ADC Therapeutics
ADCT
ADCT
56 hedge funds and large institutions have $97.5M invested in ADC Therapeutics in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
23% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 13
80% less call options, than puts
Call options by funds: $5K | Put options by funds: $25K
Holders
56
Holding in Top 10
2
Calls
$5K
Puts
$25K
Top Buyers
| 1 | +$5M | |
| 2 | +$4M | |
| 3 | +$1.04M | |
| 4 |
Morgan Stanley
New York
|
+$462K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$446K |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$2.92M | |
| 3 | -$2.61M | |
| 4 |
Millennium Management
New York
|
-$793K |
| 5 |
JPMorgan Chase & Co
New York
|
-$713K |